Presentation TCT 2015 Debate: Is It Necessary to Implant 3-D Cardiac Structures? In Which Setting? Yes, With Cadaveric Matrices Native Myocardial Architecture Is Mandatory! Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Doris A. Taylor October 15, 2015
Presentation TCT 2015 Debate: Is It Necessary to Implant 3-D Cardiac Structures? In Which Setting? Yes, With Bioartificial Matrices, Which Are Available and Versatile! Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Felipe Prosper October 15, 2015
Presentation TCT 2015 Stem CellBased Ablation for Ventricular Arrhythmias Presenter: Nabil Dib, Philippe Menasché, Angel Arenal October 15, 2015
Presentation TCT 2015 In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? No Cell Works. Genes are the Answer. Presenter: Nabil Dib, Philippe Menasché, Marc S. Penn October 15, 2015
Presentation TCT 2015 In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiac Progenitor Cells Are the Only One! Presenter: Nabil Dib, Philippe Menasché, Timothy D. Henry October 15, 2015
Presentation TCT 2015 In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Combination of Cells for Additive Effects: This Is the Key! Presenter: Nabil Dib, Philippe Menasché, Jay H Traverse October 15, 2015
Presentation TCT 2015 In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiopoietic Commitment Is the Key! Presenter: Nabil Dib, Philippe Menasché, Amit Patel October 15, 2015
Presentation TCT 2015 Disappointing Clinical Trial Experiences to Date: Should We Continue? In Which Setting? How? Presenter: Francisco Fdez-Aviles, Timothy D. Henry October 15, 2015
Presentation TCT 2015 Stem Cells in Biology of the Adult Myocardium: Are Biomaterials the Missing Link? Presenter: Francisco Fdez-Aviles, Timothy D. Henry, Jay H Traverse October 15, 2015
Presentation TCT 2015 Cell-Based Therapies to Prevent and Cure Heart Failure: More Than an Adventure Presenter: Francisco Fdez-Aviles, Timothy D. Henry, Douglas W. Losordo October 15, 2015
Presentation TCT 2015 TCT 107: The DISCOVER Registry One-Year Outcomes of a Fully Repositionable and Retrievable Nonmetallic Transcatheter Aortic Valve in a Real-World Population Presenter: Steven R. Bailey, Patrick W. Serruys, Federico De Marco October 15, 2015
Presentation TCT 2015 FDA-Approved or US IDE Studies: DIRECT FLOW Technical Specifications and Clinical Trial Results (DISCOVER and SALUS Clinical Studies) Presenter: Ariel Finkelstein, Ganesh Manoharan, Isaac George October 14, 2015
Presentation TCT 2015 I Dont Believe DAPT Should Be Discontinued at or Before 12 Months After Elective DES Implantation! Presenter: Eric R. Bates, Spencer B. King III, Daniel I. Simon October 13, 2015
News Conference News TCT 2015 RIVER-PCI: No Advantage to Ranolazine in Patients With Incomplete Revascularization Yael L. Maxwell October 13, 2015
Presentation TCT 2015 CFR/FFR/IMR/HMR Discordance: Understanding the Differences Presenter: Justin E. Davies, Bernard De Bruyne, Jan J. Piek October 12, 2015
News Conference News TCT 2015 Very Late Stent Thrombosis Remains an Important Clinical Target October 12, 2015
News Conference News TCT 2015 LAA Closure Trials Illustrate Evolution of Devices, Trial Design October 12, 2015
News Conference News TCT 2015 Featured Lecture Calls for Integration of New Technologies to Improve Cath Lab Care Yael L. Maxwell October 12, 2015
News Conference News TCT 2015 DISCOVER Registry: Positive Results Seen for Next-Generation TAVR Device at 1 Year October 12, 2015
News Conference News TCT 2015 Boston Scientific Co-founder John Abele Recognized by TCT Career Achievement Award October 12, 2015